| abstract |
There is provided a contrast medium composition comprising: (a) a first contrast agent comprising a physiologically tolerable manganese compound, a physiologically tolerable reducing compound containing an alpha -hydroxy ketone group, or salt thereof, having a manganese concentration of at least 0.3 mM or being in a dosage unit form containing at least 300 mu mol manganese, together with (b) a second contrast agent. Such compositions have been found to be particularly suited to imaging of the liver. |